Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Dnajc18 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of DNAJC18 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Dnajc18 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC18 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of DNAJC18 mRNA | CTD | PMID:29097150 | 1H-pyrazole | increases expression | ISO | Dnajc18 (Mus musculus) | 6480464 | pyrazole results in increased expression of DNAJC18 mRNA | CTD | PMID:17945193 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Dnajc18 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of DNAJC18 mRNA | CTD | PMID:21570461 | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of DNAJC18 mRNA | CTD | PMID:21061450 | 4,4'-sulfonyldiphenol | increases methylation | ISO | DNAJC18 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of DNAJC18 gene | CTD | PMID:31601247 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of DNAJC18 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | DNAJC18 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of DNAJC18 gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of DNAJC18 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | decreases methylation | ISO | DNAJC18 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of DNAJC18 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DNAJC18 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of DNAJC18 mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DNAJC18 mRNA | CTD | PMID:29097150 and PMID:30816183 | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of DNAJC18 mRNA | CTD | PMID:22110744 | carbamazepine | affects expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of DNAJC18 mRNA | CTD | PMID:24752500 | CGP 52608 | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DNAJC18 gene] | CTD | PMID:28238834 | chenodeoxycholic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | cisplatin | increases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of DNAJC18 mRNA | CTD | PMID:27392435 | cyclosporin A | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA | CTD | PMID:32152650 | deoxycholic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | diclofenac | affects expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Diclofenac affects the expression of DNAJC18 mRNA | CTD | PMID:24752500 | dorsomorphin | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | entinostat results in decreased expression of DNAJC18 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DNAJC18 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | ISO | Dnajc18 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC18 mRNA | CTD | PMID:22206623 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of DNAJC18 gene | CTD | PMID:22079235 | glycochenodeoxycholic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | glycocholic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | glycodeoxycholic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of DNAJC18 mRNA | CTD | PMID:21396975 | methylmercury chloride | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of DNAJC18 mRNA | CTD | PMID:28001369 | nefazodone | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC18 mRNA | CTD | PMID:32152650 | nickel atom | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Nickel results in decreased expression of DNAJC18 mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DNAJC18 mRNA | CTD | PMID:33387578 | pirinixic acid | decreases expression | ISO | Dnajc18 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of DNAJC18 mRNA | CTD | PMID:20813756 | resveratrol | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC18 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of DNAJC18 mRNA | CTD | PMID:28595984 and PMID:34032870 | Sunset Yellow FCF | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of DNAJC18 mRNA | CTD | PMID:33819548 | tartrazine | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA | CTD | PMID:33819548 | trichostatin A | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of DNAJC18 mRNA | CTD | PMID:24935251 | valproic acid | affects expression | ISO | Dnajc18 (Mus musculus) | 6480464 | Valproic Acid affects the expression of DNAJC18 mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of DNAJC18 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | DNAJC18 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DNAJC18 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | DNAJC18 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of DNAJC18 mRNA | CTD | PMID:27188386 | |